https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48692 Tue 28 Mar 2023 20:45:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50837 Thu 17 Aug 2023 11:53:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50902 weekly) (aOR: 2.10, 95% CI: 1.13, 3.90, and 2.73, 95% CI: 1.52, 4.93 for males and females respectively). Among other drugs, using ecstasy was also significantly associated with HSRSB in both genders (aOR: 3.97, 95% CI: 1.17, 13.42 and aOR: 5.32, 95% CI: 2.05, 13.82 for males and females). The combined impact of mental health conditions was substantially higher among females than males (PAR%: 46% and 27%, respectively). The findings may inform the targeting of health promotion programs for STI prevention towards those at higher risk due to methamphetamine use and mental health issues.]]> Thu 10 Aug 2023 13:24:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49563 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.]]> Mon 22 May 2023 09:20:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39331 Fri 19 Apr 2024 11:23:25 AEST ]]>